Research Meetings Intelligence

Home›Research›CLN.S

RESEARCH COLLECTION

CLN.S Research Reports and Analyst Coverage

Recent institutional research covering CLN.S, ordered by publication date.

Clariant AG (CLN.S): 2Q26:13% EBITDA beat, Catalysts stronger than feared, closing negative Catalyst Watch2026-07-31 · Citi · CLN.S Clariant AG (CLN.S): Removing Downside 90-Day Catalyst Watch2026-07-31 · Citi · CLN.S

Important information

Research excerpts are provided for discovery and do not constitute investment advice.